Whole-genome sequencing (WGS) has transformed our understanding of antimicrobial resistance, yielding new insights into the genetics underlying resistance. To date, most studies using WGS to study antimicrobial resistance have focused on gram-negative bacteria in the family Enterobacteriaceae, such as Salmonella spp. and Escherichia coli, which have well-defined resistance mechanisms. In contrast, relatively few studies have been performed on gram-positive organisms. We sequenced 197 strains of Enterococcus from various animal and food sources, including 100 Enterococcus faecium and 97 E. faecalis. From analyzing acquired resistance genes and known resistance-associated mutations, we found that resistance genotypes correlated with resistance phenotypes in 96.5% of cases for the 11 drugs investigated. Some resistances, such as those to tigecycline and daptomycin, could not be investigated due to a lack of knowledge of mechanisms underlying these phenotypes. This study showed the utility of WGS for predicting antimicrobial resistance based on genotype alone.
INTRODUCTION
Antimicrobial resistance is a significant threat to public health, causing approximately 700 000 deaths annually worldwide (Jasovsky et al. 2016) . Bacteria of the genus Enterococcus are among the leading causes of hospital-acquired infections in the USA, contributing to soft-tissue, bloodstream and urinary tract infections, among others (Babady 2016) . A common difficulty in treating these infections results from the fact that resistance among enterococci has been increasing, including resistance to vancomycin (Arias and Murray 2012) . With the introduction of newer therapeutics, there are now more options to treat Enterococcus infections, but there are still risks of treatment failure (Chuang et al. 2014) . Enterococcus is also a common sentinel organism in national surveillance systems tracking antimicrobial resistance through the food chain (WHO-AGISAR 2013) . Its ubiquity in humans and animals makes it a marker of fecal contamination and a target for assessing resistance to antimicrobials with activity against gram-positive organisms.
Whole-genome sequencing (WGS) has become a routine process in many laboratories, and is rapidly being adopted by public health systems worldwide. WGS is used currently to characterize Salmonella, Campylobacter and Escherichia coli collected by the National Antimicrobial Resistance Monitoring System (NARMS) (FDA 2017) , where previous studies showed the power of WGS to predict antimicrobial resistance in these genera (Tyson et al. 2015; Zhao et al. 2015; McDermott et al. 2016) . Comparatively little information exists to correlate the presence of resistance determinants to phenotypic resistance in Enterococcus and other gram-positive bacteria. Numerous studies have correlated genotypes with phenotypes for various drugs in mycobacteria (Ocheretina et al. 2014; Bauskenieks et al. 2015) , as well as one significant study in Staphylococcus aureus (Gordon et al. 2014) . Only one large study has performed similar work on Enterococcus, but it was limited to 100 largely susceptible Enterococcus strains isolated from Danish swine (Zankari et al. 2013) .
This study tested a diverse set of approximately 200 strains from various animal and food sources against 15 antibacterial agents with the goal of assessing the concordance between the presence of known resistance determinants and phenotypic resistance. The overall goal of the study was to evaluate the potential value of WGS in routine resistance surveillance of Enterococcus spp.
MATERIALS AND METHODS

Enterococcus isolation and culture
Strains tested in this study were recovered as part of routine NARMS Enterococcus surveillance performed during 2014. Retail meat and cecal samples were collected throughout the USA, with Enterococcus isolation performed as previously described (Tyson et al. 2017) . Isolates in this study were selected to represent diverse isolation sources and resistance patterns (Table S1 , Supporting Information).
Antimicrobial susceptibility testing
In vitro antimicrobial susceptibility testing was performed by broth microdilution in 96-well plates, with the NARMS grampositive panel CMV3AGPF (Trek Diagnostics, Independence, OH). Clinical and Laboratory Standards Institute (CLSI) methods were used (CLSI 2015) , with quality control organisms Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 and Enterococcus faecalis ATCC 51299. The following resistance cutoffs were used: gentamicin (≥256 μg/mL), kanamycin (≥1024 μg/mL), streptomycin (≥1024 μg/mL), vancomycin (≥8 μg/mL) , erythromycin (≥8 μg/mL), tylosin (≥32 μg/mL), linezolid (≥8 μg/mL), chloramphenicol (≥32 μg/mL), ciprofloxacin (>4 μg/mL, only reported for E. faecalis), quinupristin/dalfopristin (≥8 μg/mL, only reported for E. faecium), tetracycline (≥8 μg/mL), penicillin (>16 μg/mL), nitrofurantoin (>64 μg/mL), tigecycline (≥0.5 μg/mL) and daptomycin (≥8 μg/mL).
Whole-genome sequencing
Sequencing was performed on the Illumina MiSeq R , using library preparation with 2 × 300 bp v3 reagent kits (Illumina, San Diego, CA). Sequences were assembled using CLC Genomics Workbench version 10.0 (Qiagen, Hilden, Germany), with default assembly parameters. All assembled sequences were of at least 20-fold coverage and had N50 values of at least 10 kilobases (Table S1, Supporting Information). BioSample accession numbers for individual isolates are listed in Table S1 (Supporting Information).
Sequence analysis
Sequences were analyzed for the presence of resistance genes in the ResFinder database (Zankari et al. 2012) , as well as the NCBI Pathogens Database (NCBI 2017), which comprise resistance gene sequences from GenBank, using 85% identity and length thresholds, with nucleotide BLAST analysis (Altschul et al. 1990) . Mutations in the quinolone resistance determining region of gyrA and parC were analyzed by BLAST. Mutations in pbp5 and 23S rRNA genes were similarly analyzed. Reference sequences for mutational analysis were derived from E. faecalis V583 (accession NC 004668.1) and E. faecium DO (NC 017960.1).
RESULTS
A set of 100 E. faecium and 97 E. faecalis collected from the NARMS program were selected for in vitro antimicrobial susceptibility testing and WGS. Isolates were derived from diverse sources, including cecal samples of chickens, turkeys, swine and cattle, as well as their corresponding retail meat sources (Table S1 , Supporting Information). A total of 46 isolates were pan-susceptible, with 90 isolates resistant to drugs in at least three antimicrobial classes. Isolate-level data are presented in Table S1 (Supporting Information).
Vancomycin and linezolid are among the most important therapeutics used to treat infections caused by Enterococcus. However, in our isolate collection we did not have any isolates resistant to these drugs. No van genes were identified, nor were linezolid resistance mechanisms such as 23S rRNA mutations and horizontally acquired resistance genes cfr and optrA (Wang et al. 2015) .
Only one isolate of E. faecalis was resistant to ciprofloxacin, and this isolate had both gyrA and parC mutations associated with resistance (el Amin, Jalal and Wretlind 1999); four of the susceptible isolates had parC mutations, but none had gyrA mutations. Enterococcus faecium phenotypic resistance to ciprofloxacin could not be identified, due to the limited testing range on the NARMS panel, as the highest MIC on the panel (4μg/mL) was still part of the wild-type MIC range. None of the E. faecium isolates had gyrA or parC mutations associated with resistance.
Chloramphenicol resistance was largely restricted to E. faecalis (Table 1) , with chloramphenicol acetyltransferase (cat) genes being responsible for each resistance observed. Only two genotype-phenotype discrepancies were observed among the 197 isolates, both in cases where cat genes were detected in isolates without phenotypic resistance.
Both erythromycin and tylosin are on the NARMS Enterococcus panel, and resistance was largely observed in tandem (Table S1 , Supporting Information). Among the 86 erythromycin-resistant isolates, 80 also were resistant to tylosin, with 78 of them carrying erm(B). Three isolates possessed erm(A) genes. Interestingly, the only isolate with an erm(A) gene in the absence of erm(B) did not have MICs reach the resistant breakpoint for either erythromycin or tylosin. The macrolide phosphotransferase gene mph(B) was identified in one isolate, which had MICs one dilution below the resistance cutoffs for both erythromycin and tylosin. Overall correlations were at least 96% for each macrolide in both E. faecalis and E. faecium, except for erythromycin in E. faecium (Table 1 ). This resulted from several isolates being resistant to erythromycin but not tylosin, despite no known mechanisms being present aside from msr(C), which was present in many macrolide-susceptible strains.
Streptomycin resistance was most commonly conferred by aadE (present in 48% of resistant isolates) and ant(6)-Ia (52% prevalence among resistant isolates), with str genes also identified in some E. faecalis isolates. Genotype to phenotype correlations were 97% for E. faecalis but only 88% for E. faecium, the latter resulting from a large number of isolates that were phenotypically susceptible but possessed resistance genes. This is likely because the MIC range for streptomycin on the panels was restricted to 512-2048 μg/mL, so the resistance cutoff was ≥1024 μg/mL for both E. faecium and E. faecalis, much higher than the streptomycin epidemiological cutoff value for E. faecium of 128 μg/mL. Thus, it is probable that correlations could be improved for E. faecium with wider MIC testing ranges to more accurately identify phenotypically resistant isolates. Kanamycin and gentamicin resistance were both conferred by the gene aac(6 )-aph(2 ), as well as aph(2 )-Id in some strains of E. faecium (Table 2) . Kanamycin resistance was also encoded by aph(3 )-III, with one isolate having aadD. Of the 55 isolates with aph(3 )-III, all but one also possessed erm(B), potentially indicating that they are carried together on a mobile element. Correlations were at least 95% for both gentamicin and kanamycin for both species of Enterococcus. Table 2) . Resistance phenotypes and genotypes corresponded approximately 96% of the time (Table 1) , with all 133 phenotypically resistant isolates possessing one or more resistance mechanisms. Eight susceptible isolates carried silent tet(L) and/or tet(M) genes.
Tetracycline resistance was conferred by the presence of tet(L), tet(M), and less commonly, tet(S) and tet(O) (
Quinupristin-dalfopristin is a combination drug containing both streptogramin A and B components. Enterococcus faecalis is considered intrinsically resistant, whereas E. faecium strains were found to possess mechanisms including vat(D), vat(E) and lsa(E). These confer resistance to streptogramin A antimicrobials, which appeared to be sufficient to result in quinupristindalfopristin MICs ≥8 μg/mL. Nevertheless, correlations for this drug were only 88%, the lowest among the drugs reported. Eight out of 30 resistant E. faecium lacked known genes, and 4 of 70 susceptible isolates carried a known resistance gene. Additional streptogramin resistance determinants, such as vga genes (Chesneau et al. 2005) , were not identified.
Penicillin resistance is most commonly associated with mutations in the pbp5 gene (Rice et al. 2004) . Consistent with these findings, we identified a serine or aspartate codon insertion after position 466 in four E. faecium, all of which were resistant to penicillin (Table S1 , Supporting Information). Three isolates, all resistant, also possessed the E629V variation in pbp5, which has been associated with mild increases in penicillin MICs (Rice et al. 2004) . However, additional known mutations (e.g. M485A) were not identified in any other isolates, including resistant strains, suggesting that additional genetic factors or uncharacterized mutations may be contributing to resistance to penicillins in enterococci. None of the isolates possessed known β-lactamases such as blaZ. Interestingly, six E. faecium isolates were hypersusceptible to penicillin (MIC ≤0.25 μg/mL). We found that five of these isolates possessed insertions or stop codons in pbp5, likely resulting in non-functional proteins and the hypersusceptibility phenotypes. These included mutations that would result in stop codons after K450 and W457 in different isolates, as well as a two codon insertion of lysine-glutamine after position 192 (Table S1 , Supporting Information). Due to the lack of knowledge regarding mutations in many resistant isolates, we were unable to calculate concordance between resistance genotypes and phenotypes for penicillin.
Daptomycin resistance was observed in several isolates, although only one isolate had an MIC of at least 16 μg/mL. There are no known horizontally transmissible resistance genes responsible for daptomycin resistance, although mutations in genes such as liaF, gdpD and cls are thought to influence resistance (Arias et al. 2011) . However, none of these mechanisms were identified in the isolates studied, indicating additional research is necessary to determine the daptomycin resistance mechanisms.
We also tested for susceptibility to tigecycline and nitrofurantoin. A total of eight isolates were resistant to tigecycline, with the only known mechanism involving upregulation of tetracycline resistance genes tet(L) and tet(M) (Fiedler et al. 2016) , which were also in many tigecycline-susceptible strains. Nitrofurantoin resistance mechanisms are unknown, so we were unable to assess resistance to this drug genotypically, although many isolates were resistant (Table S1 , Supporting Information).
Additional genes conferring resistance to trimethoprim, lincomycin, spectinomycin and other antimicrobials not on the NARMS panel were also identified (Table 2) . Although these drugs are not typically used to treat infections caused by Enterococcus, the resistance genes have the potential to be transmitted to other organisms that are susceptible to these drugs, or to mobilize other resistance traits under appropriate selection pressures. Some E. faecalis isolates had one of several trimethoprim resistance genes (Table 2) , although none was present in E. faecium. As expected, lsa(A), which is thought to confer the intrinsic resistance of E. faecalis to streptogramins, was found in every isolate of this species and was not present in any E. faecium. Similarly, msr(C), which in some cases may influence susceptibility to macrolide and streptogramin B antimicrobials, was only identified in E. faecium, although not every isolate of this species had this resistance gene.
DISCUSSION
Antimicrobial resistance is a critical public health issue, and surveillance of resistant strains from different environments is a vital component of any national strategy to combat antimicrobial-resistant bacteria. As WGS has become affordable, several studies have attempted to show concordance between the presence of known resistance determinants and phenotypic resistance. Some bacteria exhibit a high concordance between antimicrobial resistance phenotypic and genotypic data (e.g. Salmonella, Campylobacter and E. coli (Zankari et al. 2013; Tyson et al. 2015; Zhao et al. 2015; McDermott et al. 2016) ), including to the MIC level (Tyson et al. 2017) , while others do not (e.g. Pseudomonas, Acinetobacter (Taitt et al. 2014; Jeukens et al. 2017) ).
This study achieved several relevant goals. The correlation between the presence of known resistance determinants and phenotypic expression of resistance was high in Enterococcus, at 96.5% overall, supporting other reports on the utility of WGS for antimicrobial resistance surveillance. In addition, we documented the range of resistance genes present in a diverse set of isolates with resistance to 11 different antimicrobials. Several cases indicated the likely presence of novel resistance mechanisms for some antimicrobials, such as penicillin, quinupristindalfospristin and daptomycin. Additional research is necessary to better understand the mechanisms underlying resistance for these drugs. Lastly, new gene insertions were discovered associated with hypersusceptibility to penicillin.
Enterococci can be sources of resistance genes for other bacteria, including gram-negatives. For instance, aph(3 )-III, aadE and tet(O) are commonly found in Campylobacter, suggesting the potential for resistance transmission into other serious pathogens (Zhao et al. 2015) . In addition, tet(M) has previously been identified among Salmonella from animals and retail meats in the USA (McDermott et al. 2016) .
One surprising finding was the identification of mph(B), which to our knowledge has not previously been reported in Enterococcus. This gene has primarily been described in E. coli, although potential resistance by this gene has been hypothesized in gram-positives (Noguchi et al. 1998) . Nevertheless, this gene, along with erm(A), appears to confer only low-level resistance to erythromycin and tylosin in Enterococcus, compared to erm(B) (Table S1, Supporting Information). Additional research on macrolide resistance mechanisms is necessary, since several isolates were resistant to erythromycin but not tylosin in E. faecium, without known genetic mechanisms being present.
This study is an important step in advancing the use of WGS for resistance genotyping in Enterococcus. As more isolates are sequenced and research is done to resolve discrepancies, correlations between genotype and phenotype will be improved. The long-term goal is to help define limitations of predicting antimicrobial resistance in Enterococcus strains where only wholegenome DNA sequence data are available.
